mesowatch-logo
mesowatch
John Edwards

Reading Time: 4 mins

Published On: June 24, 2024

Page Features:12 cited research

John Edwards - author

John Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

Jump to a topic


Related Pages

divider

warning icon

Find out if you qualify for a mesothelioma lawsuit.

Asbestos Exposure in Blacksmiths

Asbestos Exposure in Blacksmiths

John Edwards

Reading Time: 4 mins

Published On: June 24, 2024

Page Features:12 cited research

John Edwards - author

John Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

Jump to a topic


warning icon

Find out if you qualify for a mesothelioma lawsuit.

12 References

divider

VIEW 0 MORE REFERENCES

Related Content

divider
WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns
WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns

Mary Pieper
3 mins read - July 8, 2024

The World Health Organization on Friday stated talc is “probably carcinogenic,” based on a study by the WHO’s International Agency for Research on Cancer (IARC).The study,...

Awareness

Promising Immunotherapy Case for Peritoneal Mesothelioma
Promising Immunotherapy Case for Peritoneal Mesothelioma

Mary Pieper
2 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant...

Treatment

Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case

Mary Pieper
4 mins read - July 2, 2024

A scientist has scored a victory over Johnson & Johnson, which alleged her influential research linking asbestos-contaminated cosmetic products to the deadly cancer...

Settlements

Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship. DMCA.com Protection Status